Filed 7 Mar 2022
Last verified 3 Oct 2026Offering in progress. A listing date has not been announced, and proposed terms may change.
Company overview
Alopexx websiteAlopexx is a clinical-stage biotechnology company. It focuses on developing broad-spectrum therapeutics to prevent, treat and mitigate bacterial, fungal and parasitic infections.
- Company country
- United States
Offering details
Base offering, before overallotment
- Exchange
- NYSE American
- Ticker
- ALPX
- Shares offered
- 3,000,000
- Shares after offering
- 8,350,506